Dimitrios Alivertis

Dr. Dimitrios Alivertis


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LPLouisa Pechlivani
Louisa Pechlivani
NNNikoleta Ntemou
Nikoleta Ntemou
Despoina PantaziDespoina Pantazi
Despoina Pantazi
Dimitrios AlivertisDimitrios Alivertis
Dimitrios Alivertis
KSKONSTANTINOS SKOBRIDIS
KONSTANTINOS SKOBRIDIS
Alexandros D. TselepisAlexandros D. Tselepis
Alexandros D. Tselepis
Nilotinib, a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia (CML), inhibits Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl-expressing cells, as well as other malignancies. In the present study, new nilotinib analogues were synthesized and fully characterized. A platelet aggregation assay was performed, and the expression of P-selectin and PAC-1, as well as the effect on the proliferation of healthy endothelial cells, were evaluated. The expression and antimetastatic effects of E-cadherin and N-cadherin were assessed. The analogues inhibited platelet aggregation in a statistically significant manner compared to nilotinib, while they exhibited a strong inhibitory effect on P-selectin and PAC-1 expression when activated by AA. All three analogues caused arrest in the mitosis phase of the HepG2 cell cycle, while analogue-1 exhibited the most potent apoptotic effect compared to nilotinib. Interestingly, none of them promoted apoptosis in HUVECs. All the analogues reduced the expression of E- and N-cadherin in different amounts, while the analogues-1 and -3 exhibited similar antimigratory effects on HepG2 cells. The results of this study reveal considerable potential to develop new tyrosine kinase inhibitors with improved antiplatelet and antitumor properties.

31 August 2024 in Viruses
Verified
Journal Article
Open access
PDF file
CDChristina Diamanti
Christina Diamanti
LNLambros Nousis
Lambros Nousis
PBPETROS BOZIDIS
PETROS BOZIDIS
MKMichalis Koureas
Michalis Koureas
MKMaria Kyritsi
Maria Kyritsi
ENEvangelia Ntzani
Evangelia Ntzani
Wastewater surveillance is crucial for the epidemiological monitoring of SARS-CoV-2. Various concentration techniques, such as skimmed milk flocculation (SMF) and polyethylene glycol (PEG) precipitation, are employed to isolate the virus effectively. This study aims to compare these two methods and determine the one with the superior recovery rates. From February to December 2021, 24-h wastewater samples were collected from the Ioannina Wastewater Treatment Plant’s inlet and processed using both techniques. Subsequent viral genome isolation and a real-time RT-qPCR detection of SARS-CoV-2 were performed. The quantitative analysis demonstrated a higher detection sensitivity with a PEG-based concentration than SMF. Moreover, when the samples were positive by both methods, PEG consistently yielded higher viral loads. These findings underscore the need for further research into concentration methodologies and the development of precise protocols to enhance epidemiological surveillance through wastewater analysis.

27 April 2025 in Molbank
Verified
Journal Article
Open access
PDF file
IGIoannis Evangelos Gerontitis
Ioannis Evangelos Gerontitis
ASABDUL KADAR SHAIKH
ABDUL KADAR SHAIKH
Dimitrios AlivertisDimitrios Alivertis
Dimitrios Alivertis
PTPanteleimon Takis
Panteleimon Takis
Anastassios TroganisAnastassios Troganis
Anastassios Troganis
GVGeorge Varvounis
George Varvounis
In this study, we examined the oxidation of (E)-2-hydroxy-1-naphthaldehyde oxime with lead tetraacetate in tetrahydrofuran that produced novel (E)-7a,8,9,10-tetrahydro-12H-naphtho[1,2-e]pyrrolo[2,1-b][1,3]oxazin-12-one oxime and 1-(pyrrolidin-1-yl)naphtho[1,2-d]isoxazole and known 7a,8,9,10-tetrahydro-12H-naphtho[1,2-e]pyrrolo-[2,1-b][1,3]oxazin-12-one in 15, 18, and 10% yields, respectively. The oxime is partially hydrolyzed to its corresponding ketone. Modifying the oxidants and reaction conditions did not improve the product yields. Based on previous studies in our laboratory, we proposed that the reactions proceed via the formation of an o-naphthoquinone nitrosomethide intermediate; 1D and 2D NMR, HRMS, IR, and UV-VIS spectra provided information that supported the structure of the products.

16 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
IGIoannis Evangelos Gerontitis
Ioannis Evangelos Gerontitis
ASABDUL KADAR SHAIKH
ABDUL KADAR SHAIKH
Dimitrios AlivertisDimitrios Alivertis
Dimitrios Alivertis
PTPetros Tsoungas
Petros Tsoungas
GVGeorge Varvounis
George Varvounis
In this study, we examined the oxidation of (E)-2-hydroxy-1-naphthaldehyde oxime with lead tetraacetate in tetrahydrofuran that produced novel (E)-7a,8,9,10-tetrahydro-12H-naphtho[1,2-e]pyrrolo[2,1-b][1,3]oxazin-12-one oxime and 1-(pyrrolidin-1-yl)naphtho[1,2-d]isoxazole, and, known 7a,8,9,10-tetrahydro-12H-naphtho[1,2-e]pyrrolo-[2,1-b][1,3]oxazin-12-one, in 15, 18 and 10% yields, respectively. The oxime is readily hydrolysed to its corresponding ketone. Modifying the oxidants and reaction conditions did not improve the product yields. Based on previous studies in our laboratory, we proposed that the reactions proceed via the formation of an o-naphthoquinone nitrosomethide intermediate. 1H and 13C NMR, HRMS, IR, and UV-VIS spectra provided information that supported the structure of the products.